loading

Karyopharm Therapeutics Inc Azioni (KPTI) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
26.37%
37.93
30.02 38.78 42.79 33.13
Operating Expenses
1.51%
62.32
63.27 65.07 70.91 66.89
Benefits Costs and Expenses
40.61%
75.14
53.44 70.83 18.93 70.42
Costs And Expenses
40.61%
75.14
53.44 70.83 18.93 70.42
Operating Income/Loss
26.67%
-24.39
-33.26 -26.28 -28.12 -33.76
Nonoperating Income/Loss
230.47%
-12.82
9.83 -5.761 51.98 -3.532
Income/Loss From Continuing Operations Before Tax
58.85%
-37.21
-23.43 -32.04 23.86 -37.29
Income Tax Expense/Benefit
11.11%
0.04
0.036 0.028 0.067 0.071
Income/Loss From Continuing Operations After Tax
58.78%
-37.25
-23.46 -32.07 23.79 -37.36
Net Income/Loss
58.78%
-37.25
-23.46 -32.07 23.79 -37.36
Preferred Stock Dividends And Other Adjustments
-
- - 5.541 -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.77%
0.00862
0.00847 0.125 121.03 115.45
Diluted Average Shares
1.77%
0.00862
0.00847 0.125 154.43 115.45
Basic Earnings Per Share
55.96%
-4.32
-2.77 -0.26 0.15 -0.32
Diluted Earnings Per Share
55.96%
-4.32
-2.77 -0.26 -0.20 -0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - 5.541 -
$24.50
price up icon 0.68%
$84.17
price down icon 0.70%
$26.47
price up icon 0.76%
$103.90
price down icon 1.11%
$131.38
price up icon 2.34%
biotechnology ONC
$307.47
price down icon 0.36%
Capitalizzazione:     |  Volume (24 ore):